Annual CFF
$19.69 M
+$10.67 M+118.30%
December 31, 2023
Summary
- As of February 7, 2025, XTNT annual cash flow from financing activities is $19.69 million, with the most recent change of +$10.67 million (+118.30%) on December 31, 2023.
- During the last 3 years, XTNT annual CFF has risen by +$20.55 million (+2386.99%).
- XTNT annual CFF is now -76.72% below its all-time high of $84.57 million, reached on December 31, 2015.
Performance
XTNT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$5.31 M
-$1.12 M-17.41%
September 30, 2024
Summary
- As of February 7, 2025, XTNT quarterly cash flow from financing activities is $5.31 million, with the most recent change of -$1.12 million (-17.41%) on September 30, 2024.
- Over the past year, XTNT quarterly CFF has dropped by -$7.53 million (-58.63%).
- XTNT quarterly CFF is now -93.68% below its all-time high of $84.14 million, reached on September 30, 2015.
Performance
XTNT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$17.25 M
-$7.53 M-30.38%
September 30, 2024
Summary
- As of February 7, 2025, XTNT TTM cash flow from financing activities is $17.25 million, with the most recent change of -$7.53 million (-30.38%) on September 30, 2024.
- Over the past year, XTNT TTM CFF has dropped by -$7.73 million (-30.94%).
- XTNT TTM CFF is now -81.01% below its all-time high of $90.84 million, reached on June 30, 2016.
Performance
XTNT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
XTNT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +118.3% | -58.6% | -30.9% |
| 3 y3 years | +2387.0% | +922.6% | +2.6% |
| 5 y5 years | +536.0% | +3442.1% | +2961.0% |
XTNT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +118.3% | -58.6% | +9761.8% | -30.9% | +2900.7% |
| 5 y | 5-year | at high | +2387.0% | -70.6% | +812.3% | -30.9% | +2103.7% |
| alltime | all time | -76.7% | +2387.0% | -93.7% | +516.6% | -81.0% | +2103.7% |
Xtant Medical Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.31 M(-17.4%) | $17.25 M(-30.4%) |
| Jun 2024 | - | $6.43 M(+24.2%) | $24.78 M(+22.1%) |
| Mar 2024 | - | $5.18 M(+1493.5%) | $20.30 M(+3.1%) |
| Dec 2023 | $19.69 M(+118.3%) | $325.00 K(-97.5%) | $19.69 M(-21.2%) |
| Sep 2023 | - | $12.84 M(+557.7%) | $24.98 M(+61.7%) |
| Jun 2023 | - | $1.95 M(-57.3%) | $15.45 M(+13.5%) |
| Mar 2023 | - | $4.57 M(-18.6%) | $13.61 M(+50.9%) |
| Dec 2022 | $9.02 M(-48.4%) | $5.61 M(+69.5%) | $9.02 M(+169.2%) |
| Sep 2022 | - | $3.31 M(+2780.0%) | $3.35 M(-652.1%) |
| Jun 2022 | - | $115.00 K(-647.6%) | -$607.00 K(-1.5%) |
| Mar 2022 | - | -$21.00 K(-61.8%) | -$616.00 K(-103.5%) |
| Dec 2021 | $17.50 M(-2132.2%) | -$55.00 K(-91.5%) | $17.50 M(+4.1%) |
| Sep 2021 | - | -$646.00 K(-709.4%) | $16.81 M(-3.5%) |
| Jun 2021 | - | $106.00 K(-99.4%) | $17.41 M(+0.9%) |
| Mar 2021 | - | $18.09 M(-2525.2%) | $17.27 M(-2105.2%) |
| Dec 2020 | -$861.00 K(+42.8%) | -$746.00 K(+1765.0%) | -$861.00 K(+394.8%) |
| Sep 2020 | - | -$40.00 K(-2.4%) | -$174.00 K(-40.6%) |
| Jun 2020 | - | -$41.00 K(+20.6%) | -$293.00 K(-45.0%) |
| Mar 2020 | - | -$34.00 K(-42.4%) | -$533.00 K(-11.6%) |
| Dec 2019 | -$603.00 K(-119.5%) | -$59.00 K(-62.9%) | -$603.00 K(+22.6%) |
| Sep 2019 | - | -$159.00 K(-43.4%) | -$492.00 K(+15.5%) |
| Jun 2019 | - | -$281.00 K(+170.2%) | -$426.00 K(+93.6%) |
| Mar 2019 | - | -$104.00 K(-300.0%) | -$220.00 K(-107.1%) |
| Dec 2018 | $3.10 M(+27.5%) | $52.00 K(-155.9%) | $3.10 M(-7.2%) |
| Sep 2018 | - | -$93.00 K(+24.0%) | $3.34 M(-28.3%) |
| Jun 2018 | - | -$75.00 K(-102.3%) | $4.66 M(-20.5%) |
| Mar 2018 | - | $3.21 M(+996.2%) | $5.86 M(+141.2%) |
| Dec 2017 | $2.43 M(-85.2%) | $293.00 K(-76.1%) | $2.43 M(-64.2%) |
| Sep 2017 | - | $1.23 M(+8.5%) | $6.78 M(-27.6%) |
| Jun 2017 | - | $1.13 M(-617.9%) | $9.38 M(-42.2%) |
| Mar 2017 | - | -$218.00 K(-104.7%) | $16.22 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $16.43 M(-80.6%) | $4.65 M(+21.8%) | $16.43 M(+56.4%) |
| Sep 2016 | - | $3.82 M(-52.2%) | $10.51 M(-88.4%) |
| Jun 2016 | - | $7.98 M(<-9900.0%) | $90.84 M(+8.1%) |
| Mar 2016 | - | -$8000.00(-99.4%) | $84.02 M(-0.7%) |
| Dec 2015 | $84.57 M(+835.1%) | -$1.28 M(-101.5%) | $84.57 M(-1.2%) |
| Sep 2015 | - | $84.14 M(+7152.6%) | $85.63 M(+1149.5%) |
| Jun 2015 | - | $1.16 M(+114.1%) | $6.85 M(+21.2%) |
| Mar 2015 | - | $542.00 K(-354.9%) | $5.66 M(-37.5%) |
| Dec 2014 | $9.04 M(+144.1%) | -$212.60 K(-104.0%) | $9.04 M(+4.8%) |
| Sep 2014 | - | $5.36 M(<-9900.0%) | $8.63 M(+166.0%) |
| Jun 2014 | - | -$37.30 K(-100.9%) | $3.24 M(-57.8%) |
| Mar 2014 | - | $3.93 M(-726.5%) | $7.68 M(+107.3%) |
| Dec 2013 | $3.71 M(-77.9%) | -$627.30 K(+2804.2%) | $3.71 M(-12.7%) |
| Sep 2013 | - | -$21.60 K(-100.5%) | $4.25 M(-71.6%) |
| Jun 2013 | - | $4.40 M(-9348.7%) | $14.96 M(+16.4%) |
| Mar 2013 | - | -$47.60 K(-45.2%) | $12.86 M(-23.5%) |
| Dec 2012 | $16.80 M(+90.9%) | -$86.80 K(-100.8%) | $16.80 M(-2.2%) |
| Sep 2012 | - | $10.70 M(+365.8%) | $17.19 M(+88.9%) |
| Jun 2012 | - | $2.30 M(-41.1%) | $9.10 M(-16.1%) |
| Mar 2012 | - | $3.90 M(+1223.6%) | $10.84 M(+23.1%) |
| Dec 2011 | $8.80 M(-7.0%) | $294.60 K(-88.7%) | $8.80 M(-20.9%) |
| Sep 2011 | - | $2.61 M(-35.4%) | $11.13 M(+37.0%) |
| Jun 2011 | - | $4.04 M(+116.8%) | $8.12 M(-8.5%) |
| Mar 2011 | - | $1.86 M(-29.0%) | $8.88 M(-6.2%) |
| Dec 2010 | $9.46 M(+175.3%) | $2.62 M(-759.5%) | $9.46 M(+13.3%) |
| Sep 2010 | - | -$397.50 K(-108.3%) | $8.35 M(-12.1%) |
| Jun 2010 | - | $4.79 M(+95.9%) | $9.51 M(+61.6%) |
| Mar 2010 | - | $2.45 M(+61.5%) | $5.88 M(+71.2%) |
| Dec 2009 | $3.44 M(>+9900.0%) | $1.51 M(+100.5%) | $3.44 M(+78.8%) |
| Sep 2009 | - | $755.20 K(-35.3%) | $1.92 M(+64.7%) |
| Jun 2009 | - | $1.17 M | $1.17 M |
| Dec 2008 | $0.00 | - | - |
FAQ
- What is Xtant Medical Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Xtant Medical Holdings?
- What is Xtant Medical Holdings annual CFF year-on-year change?
- What is Xtant Medical Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Xtant Medical Holdings?
- What is Xtant Medical Holdings quarterly CFF year-on-year change?
- What is Xtant Medical Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Xtant Medical Holdings?
- What is Xtant Medical Holdings TTM CFF year-on-year change?
What is Xtant Medical Holdings annual cash flow from financing activities?
The current annual CFF of XTNT is $19.69 M
What is the all time high annual CFF for Xtant Medical Holdings?
Xtant Medical Holdings all-time high annual cash flow from financing activities is $84.57 M
What is Xtant Medical Holdings annual CFF year-on-year change?
Over the past year, XTNT annual cash flow from financing activities has changed by +$10.67 M (+118.30%)
What is Xtant Medical Holdings quarterly cash flow from financing activities?
The current quarterly CFF of XTNT is $5.31 M
What is the all time high quarterly CFF for Xtant Medical Holdings?
Xtant Medical Holdings all-time high quarterly cash flow from financing activities is $84.14 M
What is Xtant Medical Holdings quarterly CFF year-on-year change?
Over the past year, XTNT quarterly cash flow from financing activities has changed by -$7.53 M (-58.63%)
What is Xtant Medical Holdings TTM cash flow from financing activities?
The current TTM CFF of XTNT is $17.25 M
What is the all time high TTM CFF for Xtant Medical Holdings?
Xtant Medical Holdings all-time high TTM cash flow from financing activities is $90.84 M
What is Xtant Medical Holdings TTM CFF year-on-year change?
Over the past year, XTNT TTM cash flow from financing activities has changed by -$7.73 M (-30.94%)